header
Maine Medicine Weekly Update: 12/24/2021

In This Issue
HAPPY HOLIDAYS FROM THE MMA
Enjoy The Holidays, Our Weekly Newsletter & Thank You For All You Do
COVID-19 CORNER
FDA Updates: Pfizer & Merck Oral Antivirals Authorized; Omicron & Monoclonal Antibodies
Maine CDC Updates & Guidance
Reminder: Everyone Ages 16 and Older Can Get a Booster Shot
US CDC Reduces Time for Health Care Workers to Isolate & Updates School Guidelines
English Study: Booster Shots Protect Against Omicron for About 10 Weeks
Patients Vaccinated for COVID-19 Have Shorter Hospital Stays Than Unvaccinated Patients
JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant
US Supreme Court to Take Up Federal COVID-19 Vaccine Rules
WHAT'S NOT COVID RELATED
CDC: Physicians Should Discuss Meds to Reduce HIV Risk
HHS: $48 Million Available to Increase the Public Health Workforce in Rural and Tribal Communities
MaineCare: Payment Cycle Reminder: Christmas and New Year's Day Holidays
IN THE NEWS
Medicine in the Media
Walgreens Pharmacy Hours Change: Call Ahead Before Picking Up Your Medication
MAINE MEDICAL ASSOCIATION JOB OPPORTUNITY
Maine Medical Education Trust (MMET) CME Program Coordinator
HEALTH COVERAGE
Open Enrollment For 2022 Individual Health Plans
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Governorís Opioid Response Seminar Webinar Series Continues (Jan 7)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Psychiatric Nurse Practitioner (PNP) - Greater Portland Health
Transformational OB/GYN or Maternal Fetal Medicine Physician leader

 
Search Back Issues



 

 

 


Follow Us:
Maine CDC Updates & Guidance

The Maine CDC has transitioned to Pfizer’s gray cap formulation for adults and adolescents (gray cap) as of Friday, December 24.

The CDC has also shut off ordering the Johnson & Johnson COVID-19 vaccine through ImmPact.

They have closed for the 1170 dose Pfizer presentation (purple cap) and transitioning to the new presentation (gray cap) with a 300 minimum dose quantity.

Download the Maine CDC memo on Pfizer’s Gray Cap Formulation and Johnson & Johnson Updates

J&J COVID-19 Vaccine Updates

On Thursday, December 16, the U.S. CDC endorsed updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19,expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine overJohnson & Johnson.

To utilize current inventory levels across Maine, we will be shutting off ordering for the Johnson & Johnson COVID-19 vaccine in ImmPact. This change will be effective Friday,

December 24. For providers who choose to continue vaccinating with the Johnson & Johnson COVID-19 vaccine, an allocation request may be submitted to:

C19Allocations.MeCDC@maine.gov

Please contact the Maine Immunization Program with any questions at 207-287-3746 or

ImmunizeME.DHHS@maine.gov

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©